Green Thumb Industries (GTBIF) Share-based Compensation Growth (3y) (2022 - 2026)
Green Thumb Industries (GTBIF) Share-based Compensation Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 12.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.89% |
| Mar 31, 2026 | 100.84% |
| Sep 30, 2025 | 13.94% |
| Jun 30, 2025 | 20.53% |
| Mar 31, 2025 | -7.70% |
| Dec 31, 2024 | 25.14% |
| Sep 30, 2024 | 18.68% |
| Jun 30, 2024 | 16.05% |
| Mar 31, 2024 | 17.20% |
| Dec 31, 2023 | 21.23% |
| Sep 30, 2023 | 17.61% |
| Jun 30, 2023 | 9.00% |
| Mar 31, 2023 | -11.39% |
| Dec 31, 2022 | 37.23% |
| Sep 30, 2022 | 30.26% |
| Jun 30, 2022 | 20.40% |
| Mar 31, 2022 | 30.90% |